Evidence map›Paper›PMID 41743774›Full record

ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2025

In-hospital prognosis of high bleeding risk patients with an acute coronary syndrome and successful percutaneous coronary intervention: a single-center real-world registry.

Charalampos Kakderis, Matthaios Didagelos, Thomas Zegkos, Konstantinos C Theodoropoulos, Antonios Kouparanis, Dimitra Ioakeimidou, Anna Iliou, George Kassimis, Stergios Tzikas, Antonios Ziakas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Charalampos KakderisFirst Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.
Matthaios DidagelosFirst Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.
Thomas ZegkosFirst Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.
Konstantinos C TheodoropoulosFirst Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.
Antonios KouparanisFirst Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.
Dimitra IoakeimidouFirst Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.
Anna IliouFirst Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.
George KassimisSecond Cardiology Department, Hippokration University Hospital, Aristotle University of Thessaloniki, Greece.
Stergios TzikasThird Cardiology Department, Hippokration University Hospital, Aristotle University of Thessaloniki, Greece.
Antonios ZiakasFirst Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The management of high bleeding risk (HBR) patients with an acute coronary syndrome (ACS) who undergo percutaneous coronary intervention (PCI) is challenging because these patients combine a severe thrombotic burden with a significant risk of bleeding complications. Aim: The aim of this study was to quantify the prevalence of HBR patients in a real-world ACS population, identify their in-hospital prognosis, and record their bleeding complications compared to non-HBR patients. Material and methods: In this real-world registry, patients with an ACS who had undergone successful revascularization with PCI were classified into HBR and non-HBR based on the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and were monitored during their hospitalization. Results: A total of 314 patients were enrolled: 103 HBR (32.8%) and 211 (67.2%) non-HBR. In-hospital all-cause mortality (17.4% vs. 2.84%, Conclusions: In-hospital all-cause mortality, cardiovascular mortality, and major bleeding events were significantly higher in HBR patients with an ACS compared to non-HBR patients. HBR patients with baseline impaired renal function should be carefully monitored for severe bleeding complications.

Indexed as

acute coronary syndromebleedinghigh bleeding riskpercutaneous coronary intervention

Identifiers

PMID41743774
PMCPMC12931112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.